Prostate Cancer

Please read these Terms of Use and Privacy Statement (collectively, the "Terms") carefully before using any of the box above indicates that you accept these Terms.

Prostate Cancer
x

Are you interested in exploring ongoing clinical trials for Prostate Cancer at the University of Alabama at Birmingham?

Yes

Following specialists treat  Prostate Cancer. Help us improve our data based on your experience.

Based on your feedback, we will add the specialty within 1 month


Submit

33%

33%

33%

77%

77%

0%20%40%60%80%

Specialty scores for Prostate Cancer

Overview

The prostate is the gland below a man's bladder that produces fluid for semen. Prostate cancer is common among older men. It is rare in men younger than 40. Risk factors for developing prostate cancer include being over 65 years of age, family history, and being African-American.

Symptoms of prostate cancer may include

  • Problems passing urine, such as pain, difficulty starting or stopping the stream, or dribbling
  • Low back pain
  • Pain with ejaculation

To diagnose prostate cancer, you doctor may do a digital rectal exam to feel the prostate for lumps or anything unusual. You may also get a blood test for prostate-specific antigen (PSA). These tests are also used in prostate cancer screening, which looks for cancer before you have symptoms. If your results are abnormal, you may need more tests, such as an ultrasound, MRI, or biopsy.

Treatment often depends on the stage of the cancer. How fast the cancer grows and how different it is from surrounding tissue helps determine the stage. Men with prostate cancer have many treatment options. The treatment that's best for one man may not be best for another. The options include watchful waiting, surgery, radiation therapy, hormone therapy, and chemotherapy. You may have a combination of treatments.

NIH: National Cancer Institute

FDA Approved Medicines

  • FDA approved triptorelin pamoate, sold as Trelstar LA, manufactured by Debiopharm as intramuscular injection for the treatment of advanced stage prostate cancer ( Prostate Cancer ) in year 2001.
  • FDA approved leuprolide acetate for depot suspension, sold as Lupron Depot, manufactured by Abbott Laboratories for the treatment of advanced prostate cancer ( Prostate Cancer ) in year 1996.
  • FDA approved sipuleucel-T, sold as Provenge, manufactured by Dendreon for the treatment of hormone refractory prostate cancer ( Prostate Cancer ) in year 2010.
  • FDA approved leuprolide acetate, sold as Eligard, manufactured by Atrix Laboratories for the palliative treatment of advanced prostate cancer ( Prostate Cancer ) in year 2002.
  • FDA approved 10.8 mg goserelin acetate implant, sold as Zoladex, manufactured by AstraZeneca for the treatment of advanced prostate cancer ( Prostate Cancer ) in year 1996.
  • FDA approved abarelix for injectable suspension, sold as Plenaxis, manufactured by Praecis Pharmaceuticals for the treatment of advanced prostate cancer ( Prostate Cancer ) in year 2003.
  • FDA approved flutamide, sold as Eulexin, manufactured by Schering-Plough for the treatment of prostate cancer ( Prostate Cancer ) in year 1996.
  • FDA approved cabazitaxel, sold as Jevtana, manufactured by sanofi aventis for the treatment of prostate cancer ( Prostate Cancer ) in year 2010.
  • FDA approved radium Ra 223 dichloride, sold as Xofigo, manufactured by Bayer Healthcare Pharmaceuticals for the treatment of prostate cancer with bone metastases ( Bone Cancer | Bone Marrow Disease | Prostate Cancer ) in year 2013.
  • FDA approved abiraterone acetate, sold as Zytiga, manufactured by Centocor Ortho Biotech for the treatment of prostate cancer ( Prostate Cancer ) in year 2011.
  • FDA approved leuprolide acetate implant, sold as Viadur, manufactured by Alza for pain relief in men with advanced prostate cancer ( Prostate Cancer ) in year 2000.
  • FDA approved triptorelin pamoate, sold as Trelstar Depot, manufactured by Debio Rechereche Pharmaceutique, Target Research Associates for the palliative treatment of advanced prostate cancer ( Prostate Cancer ) in year 2000.
  • FDA approved degarelix for injection, sold as Degarelix, manufactured by Ferring Pharmaceuticals for the treatment of prostate cancer ( Prostate Cancer ) in year 2008.